$25.03+0.03 (+0.12%)
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Avanos Medical, Inc. in the Healthcare sector is trading at $25.03. The stock is currently near its 52-week high of $25.49, remaining 67.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, ...
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Avanos Medical stock: context for recent performance Avanos Medical (AVNS) has drawn fresh attention after a strong past 3 months, during which the stock returned about 81%. That move comes alongside annual revenue of $715.9 million and a reported net loss of $74.4 million. See our latest analysis for Avanos Medical. That surge sits in contrast to a longer track record where the 1 year total shareholder return is about 100.3%, while the 3 year total shareholder return declined 2.4% and the 5...
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.